Home > Journals > Minerva Pediatrica > Past Issues > Minerva Pediatrica 2009 June;61(3) > Minerva Pediatrica 2009 June;61(3):263-72

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA PEDIATRICA

A Journal on Pediatrics, Neonatology, Adolescent Medicine,
Child and Adolescent Psychiatry


Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,532


eTOC

 

REVIEWS  INTESTINAL FAILURE AND REHABILITATION


Minerva Pediatrica 2009 June;61(3):263-72

language: English

What is the current role for parenteral lipid emulsions containing omega-3 fatty acids
in infants with short bowel syndrome?

Diamond I. R., Pencharz P. B., Wales P. W.

Group for Improvement of Intestinal Function and Treatment (GIFT) Hospital for Sick Children, Toronto, ON, Canada


PDF  


Parenteral nutrition associated liver disease is the most common complication of pediatric short bowel syndrome (SBS). There is emerging evidence that the disease may be reversed with the use of parenteral lipid emulsions derived from fish-oils, which contain significant concentrations of omega-3 fatty acids (w3FA). This paper will review the rationale for the use of parenteral lipid emulsions containing w3FA in SBS and the evidence for their efficacy. Given the promising results and apparent safety of these emulsions, we shall also consider what the current role for PN lipid emulsions containing w3FA in children with SBS should be.

top of page

Publication History

Cite this article as

Corresponding author e-mail